Genprex (GNPX) Competitors

Genprex logo
$0.44 -0.03 (-6.39%)
Closing price 02/14/2025 04:00 PM Eastern
Extended Trading
$0.43 -0.01 (-2.25%)
As of 02/14/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GNPX vs. OKUR, COCP, CARM, MIRA, ATHA, DWTX, MEIP, FNCH, MRKR, and CDIO

Should you be buying Genprex stock or one of its competitors? The main competitors of Genprex include OnKure Therapeutics (OKUR), Cocrystal Pharma (COCP), Carisma Therapeutics (CARM), MIRA Pharmaceuticals (MIRA), Athira Pharma (ATHA), Dogwood Therapeutics (DWTX), MEI Pharma (MEIP), Finch Therapeutics Group (FNCH), Marker Therapeutics (MRKR), and Cardio Diagnostics (CDIO). These companies are all part of the "pharmaceutical products" industry.

Genprex vs.

OnKure Therapeutics (NASDAQ:OKUR) and Genprex (NASDAQ:GNPX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, community ranking, valuation and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OnKure TherapeuticsN/AN/A-$77.39M-$12.20-0.47
GenprexN/AN/A-$30.86MN/AN/A

In the previous week, OnKure Therapeutics and OnKure Therapeutics both had 4 articles in the media. OnKure Therapeutics' average media sentiment score of 0.81 beat Genprex's score of -0.08 indicating that OnKure Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OnKure Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genprex
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

91.0% of OnKure Therapeutics shares are owned by institutional investors. Comparatively, 14.1% of Genprex shares are owned by institutional investors. 17.9% of OnKure Therapeutics shares are owned by company insiders. Comparatively, 8.5% of Genprex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

OnKure Therapeutics currently has a consensus price target of $36.00, suggesting a potential upside of 527.18%. Genprex has a consensus price target of $10.00, suggesting a potential upside of 2,168.09%. Given Genprex's higher probable upside, analysts clearly believe Genprex is more favorable than OnKure Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OnKure Therapeutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40
Genprex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Genprex received 194 more outperform votes than OnKure Therapeutics when rated by MarketBeat users. However, 100.00% of users gave OnKure Therapeutics an outperform vote while only 65.25% of users gave Genprex an outperform vote.

CompanyUnderperformOutperform
OnKure TherapeuticsOutperform Votes
5
100.00%
Underperform Votes
No Votes
GenprexOutperform Votes
199
65.25%
Underperform Votes
106
34.75%

OnKure Therapeutics has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500. Comparatively, Genprex has a beta of -0.96, suggesting that its share price is 196% less volatile than the S&P 500.

OnKure Therapeutics' return on equity of -51.17% beat Genprex's return on equity.

Company Net Margins Return on Equity Return on Assets
OnKure TherapeuticsN/A -51.17% -47.11%
Genprex N/A -409.48%-269.17%

Summary

OnKure Therapeutics beats Genprex on 10 of the 13 factors compared between the two stocks.

Get Genprex News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNPX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNPX vs. The Competition

MetricGenprexPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$3.75M$6.85B$5.77B$9.21B
Dividend YieldN/A2.88%5.27%3.99%
P/E RatioN/A9.0525.6519.13
Price / SalesN/A318.75475.1180.74
Price / CashN/A75.4646.0638.90
Price / Book0.095.537.275.05
Net Income-$30.86M$123.46M$3.19B$222.81M
7 Day Performance-10.51%1.37%1.67%1.29%
1 Month Performance-38.76%2.09%4.11%1.52%
1 Year Performance-89.98%1.28%22.10%16.53%

Genprex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNPX
Genprex
4.5191 of 5 stars
$0.44
-6.4%
$10.00
+2,168.1%
-90.0%$3.75MN/A0.0020Short Interest ↓
Gap Down
High Trading Volume
OKUR
OnKure Therapeutics
3.3822 of 5 stars
$5.85
-5.0%
$36.00
+515.9%
N/A$19.59MN/A-0.48N/A
COCP
Cocrystal Pharma
3.5694 of 5 stars
$1.91
-4.2%
$7.00
+267.3%
+23.0%$19.48MN/A-1.0410Positive News
Gap Down
CARM
Carisma Therapeutics
3.3958 of 5 stars
$0.47
+1.1%
$4.94
+962.4%
-78.6%$19.41M$14.92M-0.3020Gap Down
MIRA
MIRA Pharmaceuticals
2.5115 of 5 stars
$1.16
-3.8%
$14.00
+1,112.1%
+11.5%$19.19MN/A-2.072Positive News
ATHA
Athira Pharma
3.6034 of 5 stars
$0.49
-6.7%
$13.83
+2,723.1%
-86.9%$18.95MN/A-0.1740Upcoming Earnings
Short Interest ↓
Positive News
DWTX
Dogwood Therapeutics
N/A$14.29
+14.4%
N/AN/A$18.84MN/A-2.165Gap Down
MEIP
MEI Pharma
4.5513 of 5 stars
$2.79
-2.3%
$7.00
+151.3%
-38.7%$18.55M$65.30M-0.40100Earnings Report
Positive News
Gap Down
FNCH
Finch Therapeutics Group
N/A$11.39
+1.2%
N/A+500.0%$18.34M$110,000.00-1.29190
MRKR
Marker Therapeutics
4.3778 of 5 stars
$1.69
-8.1%
$19.00
+1,023.6%
-58.0%$18.31M$3.31M0.0060Short Interest ↑
Gap Down
CDIO
Cardio Diagnostics
2.0959 of 5 stars
$0.44
+0.9%
$2.00
+351.5%
-62.4%$17.92M$20,000.000.001Negative News

Related Companies and Tools


This page (NASDAQ:GNPX) was last updated on 2/17/2025 by MarketBeat.com Staff
From Our Partners